Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZBTB47 and NKTR antisense RNA 1 (ZBTB47-AS1) is an annotated long noncoding RNA locus. It is described as an antisense transcript overlapping or neighboring the ZBTB47 and NKTR genes on the human genome[3][5]. Antisense RNAs are known to play varied roles in the regulation of gene expression at the transcriptional and post-transcriptional level, mainly by interfering with their complementary sense transcripts or modifying local chromatin environments[2]. The specific biological function, disease relevance, and therapeutic potential of ZBTB47-AS1 have not been determined; this RNA is mainly listed in genome annotation databases without functional or clinical characterization[3][5].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZBTB47 and NKTR antisense RNA 1 (ZBTB47-AS1).